Prostate cancer decisions — 2003

The Board found that the veteran's pension is based on multiple service-connected disabilities, which combine for a rating of 100 percent. The need for regular aid and attendance was denied as he does not meet the criteria outlined in VA regulations.

The Board found that the veteran's service connection for metastatic prostate cancer was not established, and there is no evidence of exposure to herbicides or other presumptive conditions in Vietnam. The cause of death due to metastatic prostate cancer was therefore denied.

The veteran's prostate cancer, presumed due to Agent Orange exposure, was rated at 20 percent from December 1, 1994, until November 11, 1997, when it recurred and the rating was increased to 100 percent.

The veteran's prostate cancer is found to be related to his military service, specifically exposure to herbicides like Agent Orange during his time in the Republic of Korea. The Board grants service connection for this condition.

The appeal has been dismissed as the appellant withdrew their appeal before a decision was made.

The veteran's appeal for a compensable rating for residuals of prostate cancer is dismissed, and his claim for an increase in special monthly compensation based on loss of use of a creative organ is denied.

The Board denied service connection for prostate cancer, finding that the claimant's prostate cancer was not incurred as a result of ionizing radiation exposure during active service.

The VA denied the veteran's claim for compensation due to prostate cancer as a result of VA medical treatment, finding that there was no evidence of carelessness or negligence on the part of the VA.

The veteran's urinary problem as a residual of prostate cancer is rated at 60 percent, requiring the use of absorbent materials which must be changed more than four times per day.

The Board has determined that the veteran's prostate cancer is not related to his military service, and thus denied his claim for service connection.

The Board has determined that the veteran's prostate cancer is at least as likely as not related to his exposure to ionizing radiation during service in Nagasaki, and thus grants service connection for this condition.

The veteran's prostate cancer is being reviewed due to presumed exposure to radiation during nuclear weapons testing. The case has been remanded for further development, including the submission of evidence regarding his specific exposure levels and referral to the VA Under Secretary for Benefits.

The veteran's postoperative prostate cancer was granted an increased rating to 60 percent effective March 2, 2001.

The Board denied the veteran's claim for an increased disability rating for residuals of prostatectomy, finding that his prostate cancer is cured and does not require any current treatment or symptoms. The VA rated him based on voiding dysfunction, but found no evidence of such dysfunction.

The veteran's claim for service connection for prostate cancer, which he claims is due to herbicide agents used in Vietnam, has been remanded by the Board. The case will be scheduled for a personal hearing and a statement of the case concerning his income eligibility for pension benefits will also be provided.

The Board has determined that the veteran did not have prostate cancer, hearing loss, hypertension, or a back disorder during his active service. The Board also found no evidence of such conditions within one year after separation from active service. Therefore, the claims for these conditions are denied.

The Board found that the veteran's prostate cancer and squamous cell carcinoma were not caused by his exposure to ionizing radiation during service, and thus denied service connection for these conditions.

The Board denied the veteran's claim for service connection for prostate cancer, which he claimed was due to exposure to ionizing radiation during his military service. The RO followed procedures under 38 C.F.R. § 3.311 and determined that there was no evidence of radiogenic disease or sufficient radiation exposure to support a grant of service connection.

The Board denied the veteran's request to restore a 100% rating for prostate cancer residuals and granted an increased rating to 40%. The veteran underwent radical prostatectomy in August 1998, but did not require further treatment. His current condition includes urinary incontinence requiring absorbent materials more than four times per day.

The Board found that the cause of death, transitional cell carcinoma of the bladder and prostate cancer, was not incurred or aggravated by active service. The exposure to Agent Orange during service is also not presumed.